Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus

British Journal of Dermatology

Volumn 162, Issue 3, 2010, Pages 674-676

  Vieira Dos Santos, R ^a   Magerl, M ^a   Martus, P ^a   Zuberbier, T ^a   Church, M K ^a   Escribano, L ^b   Maurer, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

Author keywords

Dermal allergy; Pruritus; Skin prick test; Sodium cromoglicate; Urticaria

Indexed keywords

ALLERGEN; CODEINE; CROMOGLYCATE DISODIUM; HISTAMINE; PLACEBO; ANTIALLERGIC AGENT;

ADULT; ALLERGIC DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; ERYTHEMA; FEMALE; HUMAN; MALE; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKIN TEMPERATURE; SKIN TINGLING; URTICARIA; URTICARIA PIGMENTOSA; DERMATITIS, ALLERGIC CONTACT; DRUG EFFECTS; INTRADERMAL DRUG ADMINISTRATION; SEVERITY OF ILLNESS INDEX; SKIN; SKIN TEST; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, CUTANEOUS; ADULT; ALLERGENS; ANTI-ALLERGIC AGENTS; CROMOLYN SODIUM; DERMATITIS, ALLERGIC CONTACT; FEMALE; HISTAMINE; HUMANS; MALE; PRURITUS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SKIN; SKIN TESTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76949102630     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09516.x     Document Type: Article

References (15)

1. Stainer R, Matthews S, Arshad SH et al. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial. Br J Dermatol 2005 152 : 334 341.
2. Moore C, Ehlayel MS, Junprasert J, Sorensen RU. Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis. Ann Allergy Asthma Immunol 1998 81 : 452 458.
3. Cox JSG. Disodium cromoglycate (FPL 670, Intal): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature 1967 216 : 1328 1329.
4. Norris AA. Pharmacology of sodium cromoglycate. Clin Exp Allergy 1996 26 (Suppl. 4 5 7.
5. dos Santos RV, Mlynek A, Lima HC et al. Beyond flat weals: validation of a three-dimensional imaging technology that will improve skin allergy research. Clin Exp Dermatol 2008 33 : 772 775.
6. Kimata H, Igarashi M. Inhibition of human allergic skin reactions in vivo by pretreatment with cromolyn (disodium-cromoglycate). Allergy 1990 45 : 393 395.
7. Ting S, Zweiman B, Lavker RM. Cromolyn does not modulate human allergic skin reactions in vivo. J Allergy Clin Immunol 1983 71 : 12 17.
8. Okayama Y, Benyon RC, Rees PH et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast-cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 1992 22 : 401 409.
9. Twycross R, Greaves MW, Handwerker H et al. Itch: scratching more than the surface. QJM 2003 96 : 7 26.
10. Petersen LJ, Church MK, Skov PS. Histamine is released in the weal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin Exp Allergy 1997 27 : 284 296.
11. Collier JG, Fuller RW. Evidence for an effect of sodium cromoglycate on sensory nerves in man. Br J Clin Pharmacol 1983 16 : 639 643.
12. Dixon M, Jackson DM, Richards IM. The action of sodium cromoglycate on 'C' fibre endings in the dog lung. Br J Pharmacol 1980 70 : 11 13.
13. Ahluwalia P, McGill JI, Church MK. Nedocromil sodium inhibits histamine-induced itch and flare in human skin. Br J Pharmacol 2001 132 : 613 615.
14. Alton EW, Norris AA. Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma. J Allergy Clin Immunol 1996 98 : S102 5.
15. Willis EF, Clough GF, Church MK. Investigation into the mechanisms by which nedocromil sodium, frusemide and bumetanide inhibit the histamine-induced itch and flare response in human skin in vivo. Clin Exp Allergy 2004 34 : 450 455.